Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 99,300
-4,200 (-4.06%)
Apr 10, 2026, 3:30 PM KST
Kolon TissueGene Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -192,587 | -33,799 | -17,224 | -11,136 | -47,370 |
Depreciation & Amortization | 784.02 | 808.55 | 1,412 | 1,665 | 1,551 |
Loss (Gain) From Sale of Assets | -37.35 | -1.02 | 2.17 | - | 14.87 |
Stock-Based Compensation | 112.73 | 79.18 | 67.24 | - | - |
Provision & Write-off of Bad Debts | 29.75 | 3.14 | -29.57 | 241.9 | -107.67 |
Other Operating Activities | 172,265 | 13,103 | -664.36 | -5,653 | 924 |
Change in Accounts Receivable | 28.36 | -57.29 | -120.38 | 58.7 | 343.57 |
Change in Inventory | 34.46 | -34.56 | -47.43 | 89.39 | 124.41 |
Change in Accounts Payable | -19.44 | 71.87 | 150.82 | 12.34 | -151.61 |
Change in Income Taxes | - | - | - | - | -218.54 |
Change in Other Net Operating Assets | -4,624 | -626.28 | -7,655 | -12,054 | 4,870 |
Operating Cash Flow | -24,014 | -20,452 | -24,109 | -26,776 | -40,020 |
Capital Expenditures | -1,196 | -129.26 | -260.58 | -68.52 | -548.04 |
Sale of Property, Plant & Equipment | 60.16 | 1.99 | 1.36 | - | 0.25 |
Sale (Purchase) of Intangibles | -116,270 | -77,123 | -45,937 | -24,275 | -5,589 |
Investment in Securities | -14,222 | - | 17,196 | -15,557 | 39,576 |
Other Investing Activities | -20.38 | 5.24 | -39.24 | -156.38 | -89.34 |
Investing Cash Flow | -131,649 | -77,245 | -29,039 | -40,057 | 33,419 |
Long-Term Debt Issued | 180,012 | 23,822 | - | - | - |
Total Debt Issued | 180,012 | 23,822 | - | - | - |
Short-Term Debt Repaid | - | - | - | - | -5,722 |
Long-Term Debt Repaid | -1,417 | -1,291 | -1,165 | -1,103 | -3,923 |
Total Debt Repaid | -1,417 | -1,291 | -1,165 | -1,103 | -9,645 |
Net Debt Issued (Repaid) | 178,596 | 22,532 | -1,165 | -1,103 | -9,645 |
Issuance of Common Stock | 43,463 | 46,937 | 39,268 | 37,366 | 34,227 |
Other Financing Activities | 0 | -0 | - | 30,646 | - |
Financing Cash Flow | 222,058 | 69,468 | 38,102 | 66,909 | 24,582 |
Foreign Exchange Rate Adjustments | -28.77 | -45.52 | 6.64 | -4.43 | 5.09 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | - |
Net Cash Flow | 66,367 | -28,274 | -15,039 | 72.76 | 17,986 |
Free Cash Flow | -25,210 | -20,581 | -24,370 | -26,844 | -40,568 |
Free Cash Flow Margin | -488.69% | -405.66% | -657.56% | -283.88% | -1013.40% |
Free Cash Flow Per Share | -306.81 | -267.44 | -339.84 | -404.97 | -662.52 |
Cash Interest Paid | - | - | - | - | 119.8 |
Cash Income Tax Paid | 27.32 | -95.76 | 251.76 | 1,318 | - |
Levered Free Cash Flow | 92,843 | -46,515 | -54,983 | -38,159 | -25,649 |
Unlevered Free Cash Flow | 92,899 | -46,459 | -54,804 | -37,927 | -25,358 |
Change in Working Capital | -4,581 | -646.25 | -7,672 | -11,894 | 4,968 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.